Agony over ecstasy: FDA bid shows it’s hard to test psychedelics
The first attempt to win government approval of a psychedelic drug for mental health treatment is generating skepticism about its clinical trials, a case that reveals the unique challenges of bringing mind-altering, illegal drugs into mainstream medical …